REGN

XNAS

REGENERON PHARMACEUTICALS

Avg. sentiment

-0.20neutral

2 news · 90d

7d trend

-0.20—

2 news · vs previous 7d (—)

Breakdown

↑ 0• 2↓ 0

Sentiment scores computed by AI · Not investment advice.

No price data available for this ticker.

News · 2

Yahoo4/24/2026, 3:00:00 PM
Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims
Eli Lilly's new oral GLP-1 weight-loss drug is reportedly seeing prescription volumes trail Novo Nordisk's oral Wegovy. JPMorgan has initiated coverage on Hims & Hers Health. Regeneron is offering a new hearing-loss therapy at no cost.
AI-generated content for informational purposes only. Not investment advice.
Sentiment -0.10Relevance 20%
Yahoo4/24/2026, 10:46:00 AM
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
Eli Lilly shares fell as its obesity drug Foundayo showed a weaker early commercial trajectory compared to oral Wegovy, while Novo Nordisk shares climbed on the contrast. Regeneron announced a drug pricing deal, and two unspecified companies disclosed leadership changes. The FDA also announced plans to issue vouchers related to psychedelic treatments.
AI-generated content for informational purposes only. Not investment advice.
Sentiment -0.30Relevance 35%